DrugPatentWatch Database Preview
NATROBA Drug Profile
Which patents cover Natroba, and when can generic versions of Natroba launch?
Natroba is a drug marketed by Parapro Llc and is included in one NDA. There are three patents protecting this drug.
This drug has forty-eight patent family members in thirty countries.
The generic ingredient in NATROBA is spinosad. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the spinosad profile page.
Summary for NATROBA
| International Patents: | 48 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 3 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for NATROBA |
| Drug Sales Revenues: | Drug sales revenues for NATROBA |
| DailyMed Link: | NATROBA at DailyMed |
Generic Entry Opportunity Date for NATROBA
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NATROBA
| Drug Class | Pediculicide |
Synonyms for NATROBA
| Comfortis |
| EC 434-300-1 |
| NaturaLyte |
| Spinosad [USAN] |
| UNII-XPA88EAP6V |
| XDE 105 |
| XPA88EAP6V |
US Patents and Regulatory Information for NATROBA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parapro Llc | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Parapro Llc | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Parapro Llc | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for NATROBA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Parapro Llc | NATROBA | spinosad | SUSPENSION;TOPICAL | 022408-001 | Jan 18, 2011 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for NATROBA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | 0201412 | ➤ Sign Up |
| Turkey | 200003818 | ➤ Sign Up |
| Taiwan | I228994 | ➤ Sign Up |
| China | 1314812 | ➤ Sign Up |
| Indonesia | 29130 | ➤ Sign Up |
| Norway | 329238 | ➤ Sign Up |
| Portugal | 968706 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for NATROBA
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0375316 | C350009 | Netherlands | ➤ Sign Up | PRODUCT NAME: SPINOSAD, DESGEWENST IN DE VORM VAN EEN ZOUT; NATL. REGISTRATION NO/DATE: 12363 N 20020913; FIRST REGISTRATION: SE 4511 20020204 |
| 0375316 | 06C0047 | France | ➤ Sign Up | PRODUCT NAME: SPINOSAD; REGISTRATION NO/DATE IN FRANCE: 2060098 DU 20060628; REGISTRATION NO/DATE AT EEC: 9275/B DU 20011023 |
| 0375316 | SPC/GB02/028 | United Kingdom | ➤ Sign Up | PRODUCT NAME: SPINOSAD; REGISTERED: CH W 6020 20010313; UK 0714 20020227 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
